184 related articles for article (PubMed ID: 19474517)
1. Epstein-Barr virus associated post-transplant Hodgkin lymphoma in an adult patient after cord blood stem cell transplantation for acute lymphoblastic leukemia.
Okuno K; Horie Y; Kanai K; Kato M; Kuwamoto S; Okazaki T; Hayashi K
J Clin Exp Hematop; 2009 May; 49(1):45-51. PubMed ID: 19474517
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of EBV-induced post-transplant Hodgkin lymphoma from Hodgkin-like post-transplant lymphoproliferative disease.
Rohr JC; Wagner HJ; Lauten M; Wacker HH; Jüttner E; Hanke C; Pohl M; Niemeyer CM
Pediatr Transplant; 2008 Jun; 12(4):426-31. PubMed ID: 18466428
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-associated post-transplant lymphoproliferative disease during dasatinib treatment occurred 10 years after umbilical cord blood transplantation.
Yamada A; Katagiri S; Moriyama M; Asano M; Suguro T; Yoshizawa S; Akahane D; Tanaka Y; Furuya N; Fujimoto H; Gotoh M; Aota Y; Nakamura N; Gotoh A
J Infect Chemother; 2021 Jul; 27(7):1076-1079. PubMed ID: 33518401
[TBL] [Abstract][Full Text] [Related]
4. Hodgkin-like posttransplant lymphoproliferative disorder in children: does it differ from posttransplant Hodgkin lymphoma?
Ranganathan S; Webber S; Ahuja S; Jaffe R
Pediatr Dev Pathol; 2004; 7(4):348-60. PubMed ID: 14564542
[TBL] [Abstract][Full Text] [Related]
5. Classical Hodgkin lymphoma type post-transplant lymphoproliferative disorder in a kidney transplant recipient: a diagnostic pitfall.
Mohri T; Ikura Y; Hirakoso A; Okamoto M; Hishizawa M; Takaori-Kondo A; Kato S; Nakamura S; Yoshimura K; Okabe H; Iwai Y
Int J Hematol; 2018 Aug; 108(2):218-227. PubMed ID: 29380181
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of a classic Hodgkin lymphoma-type post-transplant lymphoproliferative disorder with tailored chemotherapy and Epstein-Barr virus-specific cytotoxic T lymphocytes in a pediatric heart transplant recipient.
Basso S; Zecca M; Calafiore L; Rubert L; Fiocchi R; Paulli M; Quartuccio G; Guido I; Sebastiani R; Croci GA; Beschi C; Nardiello I; Ginevri F; Cugno C; Comoli P
Pediatr Transplant; 2013 Nov; 17(7):E168-73. PubMed ID: 23992468
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus post-transplant lymphoproliferative disease (PTLD) after hematopoietic stem cell transplantation.
Ru Y; Chen J; Wu D
Eur J Haematol; 2018 Sep; 101(3):283-290. PubMed ID: 29949208
[TBL] [Abstract][Full Text] [Related]
8. Orbital Epstein-Barr virus-related post-transplant lymphoproliferative disorder in a 13-year-old girl with cord blood transplantation.
Shigemura T; Maruyama Y; Shigeto S; Nakazawa Y; Kanno H
Transpl Infect Dis; 2021 Jun; 23(3):e13536. PubMed ID: 33264446
[TBL] [Abstract][Full Text] [Related]
9. Hodgkin's lymphoma after post-transplant lymphoproliferative disease in a renal transplant recipient.
Dharnidharka VR; Douglas VK; Hunger SP; Fennell RS
Pediatr Transplant; 2004 Feb; 8(1):87-90. PubMed ID: 15009846
[TBL] [Abstract][Full Text] [Related]
10. Hodgkin lymphoma-like posttransplant lymphoproliferative disorder (HL-like PTLD) simulates monomorphic B-cell PTLD both clinically and pathologically.
Pitman SD; Huang Q; Zuppan CW; Rowsell EH; Cao JD; Berdeja JG; Weiss LM; Wang J
Am J Surg Pathol; 2006 Apr; 30(4):470-6. PubMed ID: 16625093
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity in clinical course of EBV-associated lymphoproliferative disorder after allogeneic stem cell transplantation.
Meyer SC; Medinger M; Halter JP; Baldomero H; Hirsch HH; Tzankov A; Dirnhofer S; Passweg JR; Tichelli A
Hematology; 2014 Jul; 19(5):280-5. PubMed ID: 24074746
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Epstein-Barr virus--associated lymphoproliferative disorder (EBV-PTLD) and pure red cell aplasia (PRCA) with Rituximab following unrelated cord blood transplantation: a case report and literature review.
Zhu K; Chen J; Chen S
Hematology; 2005 Oct; 10(5):365-70. PubMed ID: 16273722
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr Virus-positive T-cell Lymphoproliferative Disease Following Umbilical Cord Blood Transplantation for Acute Myeloid Leukemia.
Yui S; Yamaguchi H; Imadome K; Arai A; Takahashi M; Ohashi R; Tamai H; Moriya K; Nakayama K; Shimizu A; Inokuchi K
J Nippon Med Sch; 2016; 83(1):35-42. PubMed ID: 26960588
[TBL] [Abstract][Full Text] [Related]
14. Role of Epstein-Barr virus status and immunophenotypic studies in the evaluation of exfoliative cytology specimens from patients with post-transplant lymphoproliferative disorders.
Gibson SE; Picarsic J; Swerdlow SH; Pantanowitz L
Cancer Cytopathol; 2016 Jun; 124(6):425-35. PubMed ID: 26992116
[TBL] [Abstract][Full Text] [Related]
15. Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children.
Gong JZ; Bayerl MG; Sandhaus LM; Sebastian S; Rehder CW; Routbort M; Lagoo AS; Szabolcs P; Chiu J; Comito M; Buckley PJ
Am J Surg Pathol; 2006 Mar; 30(3):328-36. PubMed ID: 16538052
[TBL] [Abstract][Full Text] [Related]
16. [Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center].
Franco A; Jiménez L; Aranda I; Alvarez L; González M; Rocamora N; Olivares J
Nefrologia; 2002; 22(5):463-9. PubMed ID: 12497748
[TBL] [Abstract][Full Text] [Related]
17. Examining the origin of posttransplant lymphoproliferative disorder in a patient after a second allogeneic hematopoeitic stem cell transplantation for relapsed BCR-ABL positive acute lymphoblastic leukemia.
Ruf S; Moser O; Wössmann W; Kreyenberg H; Wagner HJ
J Pediatr Hematol Oncol; 2011 Jan; 33(1):50-4. PubMed ID: 21178708
[TBL] [Abstract][Full Text] [Related]
18. Classical Hodgkin lymphoma-type PTLD after solid organ transplantation in children: a report on 17 patients treated according to subsequent GPOH-HD treatment schedules.
Kampers J; Orjuela-Grimm M; Schober T; Schulz TF; Stiefel M; Klein C; Körholz D; Mauz-Körholz C; Kreipe H; Beier R; Maecker-Kolhoff B
Leuk Lymphoma; 2017 Mar; 58(3):633-638. PubMed ID: 27685149
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and clinical outcomes of Epstein-Barr virus DNAemia and post-transplant lymphoproliferative disorders after haploidentical and matched-sibling PBSCT in patients with hematologic malignancies.
Gao XN; Lin J; Wang LJ; Li F; Li HH; Wang SH; Huang WR; Gao CJ; Yu L; Liu DH
Ann Hematol; 2019 Sep; 98(9):2163-2177. PubMed ID: 31243569
[TBL] [Abstract][Full Text] [Related]
20. Successful management of EBV-PTLD in allogeneic bone marrow transplant recipient by virological-immunological monitoring of EBV infection, prompt diagnosis and early treatment.
Chiereghin A; Bertuzzi C; Piccirilli G; Gabrielli L; Squarzoni D; Turello G; Ferioli M; Sessa M; Bonifazi F; Zanoni L; Sabattini E; Lazzarotto T
Transpl Immunol; 2016 Feb; 34():60-4. PubMed ID: 26687013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
